This Article  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Edited by W. J. Whelan and M. P. Cameron. Price, not given. Little, Brown and Co., 34 Beacon St., Boston, 1964.

Lewis P. Rowland, Reviewer

Arch Neurol. 1965;13(3):332.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Neurological interest in glycogen metabolism centers primarily upon two forms of glycogen storage disease. Pompe's disease affects skeletal muscle and motor neurones in addition to the heart, and McArdle's disease was the first inherited myopathy in which the enzyme defect was recognized. These conditions are discussed at length in this 1963 Ciba Foundation Symposium. Two new neurological conditions are also described: a myopathy due to lack of amylo-1,6-glucosidase (Larner) and a form of hypoglycemia due to lack of glycogen synthetase (Spencer-Peet). Schmid, Manners, Illingworth, Brown, Hers, and Larner provide comprehensive and authoritative discussions of each form of glycogen storage disease. There is an interesting general discussion of such practical considerations as the proper preparation and storage of tissue samples, and the appropriate enzymes to be assayed in new cases. There are several warnings about apparent, but not real, enzyme defects due to artifacts.

It is possible to construct a map . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?